<VariationArchive VariationID="182411" VariationName="NM_000077.5(CDKN2A):c.225_243del (p.Ala76fs)" VariationType="Deletion" Accession="VCV000182411" Version="18" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-05-27" DateCreated="2016-10-09" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="180316" VariationID="182411">
      <GeneList>
        <Gene Symbol="CDKN2A" FullName="cyclin dependent kinase inhibitor 2A" GeneID="1029" HGNC_ID="HGNC:1787" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21967752" stop="21995324" display_start="21967752" display_stop="21995324" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="21967750" stop="21994489" display_start="21967750" display_stop="21994489" Strand="-" />
          </Location>
          <OMIM>600160</OMIM>
          <Haploinsufficiency last_evaluated="2022-03-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-03-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000077.5(CDKN2A):c.225_243del (p.Ala76fs)</Name>
      <CanonicalSPDI>NC_000009.12:21971115:GGGTCGGGTGAGAGTGGCGGGGTCGG:GGGTCGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="21971115" stop="21971133" display_start="21971115" display_stop="21971133" variantLength="19" positionVCF="21971114" referenceAlleleVCF="CGGGTCGGGTGAGAGTGGCG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="21971116" stop="21971134" display_start="21971116" display_stop="21971134" variantLength="19" positionVCF="21971115" referenceAlleleVCF="CGGGTCGGGTGAGAGTGGCG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>A25fs</ProteinChange>
      <ProteinChange>A76fs</ProteinChange>
      <ProteinChange>R90fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_11" sequenceAccession="LRG_11">
            <Expression>LRG_11:g.28358_28376del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000077.4" sequenceAccession="NM_000077" sequenceVersion="4" change="c.225_243delCGCCACTCTCACCCGACCC">
            <Expression>NM_000077.4:c.225_243delCGCCACTCTCACCCGACCC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.21971122_21971140del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.21971122_21971140del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.21971123_21971141del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.21971123_21971141del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007485.1" sequenceAccession="NG_007485" sequenceVersion="1" change="g.28358_28376del">
            <Expression>NG_007485.1:g.28358_28376del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000077.5" sequenceAccession="NM_000077" sequenceVersion="5" change="c.225_243del" MANESelect="true">
            <Expression>NM_000077.5:c.225_243del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000068.1" sequenceAccession="NP_000068" sequenceVersion="1" change="p.Ala76fs">
            <Expression>NP_000068.1:p.Ala76fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195132.2" sequenceAccession="NM_001195132" sequenceVersion="2" change="c.225_243del">
            <Expression>NM_001195132.2:c.225_243del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182061.1" sequenceAccession="NP_001182061" sequenceVersion="1" change="p.Ala76fs">
            <Expression>NP_001182061.1:p.Ala76fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363763.2" sequenceAccession="NM_001363763" sequenceVersion="2" change="c.72_90del">
            <Expression>NM_001363763.2:c.72_90del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350692.1" sequenceAccession="NP_001350692" sequenceVersion="1" change="p.Ala25fs">
            <Expression>NP_001350692.1:p.Ala25fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058195.4" sequenceAccession="NM_058195" sequenceVersion="4" change="c.268_286del" MANEPlusClinical="true">
            <Expression>NM_058195.4:c.268_286del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_478102.2" sequenceAccession="NP_478102" sequenceVersion="2" change="p.Arg90fs">
            <Expression>NP_478102.2:p.Arg90fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058197.5" sequenceAccession="NM_058197" sequenceVersion="5" change="c.*148_*166del">
            <Expression>NM_058197.5:c.*148_*166del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_11t1" sequenceAccession="LRG_11t1">
            <Expression>LRG_11t1:c.225_243del19</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA299023" DB="ClinGen" />
        <XRef Type="rs" ID="730881674" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.225_243del (p.Ala76fs) AND not provided" Accession="RCV000160405" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.225_243del (p.Ala76fs) AND Familial melanoma" Accession="RCV000161946" Version="8">
        <ClassifiedConditionList TraitSetID="13761">
          <ClassifiedCondition DB="MedGen" ID="C1512419">Familial melanoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-09-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.225_243del (p.Ala76fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000493242" Version="8">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-06-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.225_243del (p.Ala76fs) AND CDKN2A-related disorder" Accession="RCV003895073" Version="1">
        <ClassifiedConditionList TraitSetID="90819">
          <ClassifiedCondition>CDKN2A-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.225_243del (p.Ala76fs) AND Melanoma-pancreatic cancer syndrome" Accession="RCV002288679" Version="2">
        <ClassifiedConditionList TraitSetID="2587">
          <ClassifiedCondition DB="MedGen" ID="C1838547">Melanoma-pancreatic cancer syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000077.5(CDKN2A):c.225_243del (p.Ala76fs) AND Melanoma and neural system tumor syndrome" Accession="RCV003474829" Version="1">
        <ClassifiedConditionList TraitSetID="2590">
          <ClassifiedCondition DB="MedGen" ID="C1835042">Melanoma and neural system tumor syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-23" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2016-10-09" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10398427</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">109563903</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10956390</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15146471</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16905682</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17047042</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18813118</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18981015</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20340136</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21614589</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22636603</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23897584</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25227142</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7640518</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9823374</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13761" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18483" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial melanoma</ElementValue>
                <XRef ID="MONDO:0018961" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary melanoma</ElementValue>
                <XRef ID="C8498" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary cutaneous melanoma</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3460" />
                <XRef ID="3460" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng14</URL>
                <CitationText>UK NICE Guideline NG14, Melanoma: assessment and management, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Melanoma: Cutaneous, 2024</CitationText>
              </Citation>
              <XRef ID="618" DB="Orphanet" />
              <XRef ID="C1512419" DB="MedGen" />
              <XRef ID="MONDO:0018961" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2587" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2742" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Melanoma-pancreatic cancer syndrome</ElementValue>
                <XRef ID="Melanoma-pancreatic+cancer+syndrome/8812" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011713" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Melanoma-pancreatic cancer syndrome is an inherited cancer predisposition syndrome in which mutation carriers have an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer (summary by Harinck et al., 2012).
For background and phenotypic information on malignant melanoma and pancreatic cancer, see 155600 and 260350, respectively.</Attribute>
                <XRef Type="MIM" ID="606719" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569524" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502978" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000325625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528916" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18473" />
                <XRef ID="18473" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <XRef ID="404560" DB="Orphanet" />
              <XRef ID="C1838547" DB="MedGen" />
              <XRef ID="MONDO:0011713" DB="MONDO" />
              <XRef Type="MIM" ID="606719" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5472" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Melanoma astrocytoma syndrome</ElementValue>
                <XRef ID="Melanoma+astrocytoma+syndrome/4577" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Melanoma and neural system tumor syndrome</ElementValue>
                <XRef ID="MONDO:0007967" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8468" />
                <XRef ID="8468" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <XRef ID="252206" DB="Orphanet" />
              <XRef ID="C1835042" DB="MedGen" />
              <XRef ID="MONDO:0007967" DB="MONDO" />
              <XRef Type="MIM" ID="155755" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="90819" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69456" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CDKN2A-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CDKN2A-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5042006" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_000077.5:c.225_243del|OMIM:606719" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002581515" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.5:c.225_243del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606719" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1_STR, PS4, PS3_SUP, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7865318" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000077.5:c.225_243del|OMIM:155755" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004212536" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.5:c.225_243del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="155755" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="381834" SubmissionDate="2021-01-07" DateLastUpdated="2021-05-10" DateCreated="2015-02-28">
        <ClinVarSubmissionID localKey="488847|MedGen:C1512419" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000211931" DateUpdated="2021-05-10" DateCreated="2015-02-28" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22636603</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20340136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23897584</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17047042</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16905682</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">109563903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7640518</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20340136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15146471</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16905682</ID>
          </Citation>
          <Comment>The CDKN2A gene encodes two different proteins, p16INK4a and p14ARF, which are translated from alternative transcripts that have different open reading frames. This sequence change deletes 19 nucleotides from exon 2 of the CDKN2A (p16INK4a) mRNA (c.225_243del), causing a frameshift at codon 76. This creates a premature translational stop signal within the last 15 codons of the penultimate exon of the CDKN2A (p16INK4a) mRNA (p.Ala76Cysfs*64). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 81 amino acids of the CDKN2A (p16INK4a) protein. Alternatively, this sequence change deletes 19 nucleotides from exon 2 of the CDKN2A (p14ARF) mRNA (c.268_286del), causing a frameshift at codon 90. This extends reading frame beyond the termination signal of the CDKN2A (p14ARF) mRNA (p.Arg90Valfs*76). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 43 amino acids of the CDKN2A (p14ARF) protein. This particular variant, also known as the p16-Leiden variant in the literature, has been reported in numerous families and individuals affected with pancreatic cancer, cutaneous malignant melanoma, and familial atypical multiple mole melanoma and is considered to be a Dutch founder mutation (PMID: 22636603, 20340136, 23897584, 17047042, 16905682, 109563903, 7640518). ClinVar contains an entry for this variant (Variation ID: 182411). Experimental studies have shown that this variant affects p16INK4a protein localization and reduces p16INK4a binding affinity to CDK4 and CDK6 (PMID: 20340136). Loss-of-function variants in CDKN2A (p16INK4a) are known to be pathogenic (PMID: 15146471, 16905682). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.21971115_21971133del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1512419" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1346889" SubmissionDate="2022-01-10" DateLastUpdated="2022-01-12" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkYliIT__ZO66geyR_uU_Yw4|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000689593" DateUpdated="2022-01-12" DateCreated="2018-02-19" Type="SCV" Version="3" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant deletes 19 nucleotides in exon 2 of the CDKN2A gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of CDKN2A function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.4:c.225_243del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Color Genomics - ClinVar Submission - May2020 - SUB747</SubmissionName>
          <SubmissionName>SUB10927044</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="376628" SubmissionDate="2022-02-23" DateLastUpdated="2023-03-04" DateCreated="2015-02-24">
        <ClinVarSubmissionID localKey="GDXSV:221556" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000210937" DateUpdated="2023-03-04" DateCreated="2015-02-24" Type="SCV" Version="13" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate a damaging effect: loss of CDK4/CDK6 binding, loss of cell cycle inhibitory activity, and altered subcellular localization (McKenzie 2010); Not observed at significant frequency in large population cohorts (gnomAD); Also known as p16-Leiden and considered a Dutch founder variant; This variant is associated with the following publications: (PMID: 16905682, 29961768, 25227142, 12549483, 23897584, 10956390, 22636603, 9579547, 7640518, 26111702, 27406244, 11815963, 21570156, 12690301, 26670666, 27267843, 27672215, 18813118, 18981015, 15146471, 28592523, 29316957, 29263814, 29769629, 30113427, 31923587, 32953120, 32482799, 31203567, 20340136)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:11923</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.4:c.225_243del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_89_20220223054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8791923" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="19282032|CDKN2A-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004716731" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CDKN2A c.225_243del19 variant is predicted to result in a frameshift and premature protein termination (p.Ala76Cysfs*64). It is also known as p16-Leiden, and reported as a Dutch founder variant. This variant has been reported in individuals with melanoma, and cancers of the pancreas and breast (Gruis et al. 1995. PubMed ID: 7640518; Koorstra et al. 2008. PubMed ID: 18813118; Li et al. 2018. PubMed ID: 29316957; Yurgelun et al. 2019. PubMed ID: 29961768). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org) and has been interpreted as pathogenic in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/182411/). Frameshift variants in CDKN2A are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.4:c.225_243del19</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CDKN2A-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1133263" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2017-07-02">
        <ClinVarSubmissionID localKey="a86508|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000581507" DateUpdated="2024-05-01" DateCreated="2017-07-02" Type="SCV" Version="6" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10398427</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10956390</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15146471</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16905682</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17047042</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18813118</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18981015</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20340136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21614589</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22636603</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25227142</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7640518</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9823374</ID>
          </Citation>
          <Comment>The c.225_243del19 pathogenic mutation, located in coding exon 2 of the CDKN2A gene, results from a deletion of 19 nucleotides at nucleotide positions 225 to 243, causing a translational frameshift with a predicted alternate stop codon (p.A76Cfs*64). This mutation has been reported in numerous individuals and families with personal and/or family history consistent with familial atypical multiple mole melanoma (FAMMM) syndrome (Gruis NA et al. Melanoma Res. 1995 Jun;5:169-77; Holland EA et al. Genes Chromosomes Cancer, 1999 Aug;25:339-48; Vasen HF et al. Int. J. Cancer, 2000 Sep;87:809-11; Goldstein AM. Hum. Mutat., 2004 Jun;23:630; Goldstein AM et al. J. Med. Genet., 2007 Feb;44:99-106; Harinck F et al. J. Med. Genet., 2012 Jun;49:362-5). Of note, this alteration is also designated as &amp;ldquo;p16-Leiden-mutation&amp;rdquo; in published literature, and has been described as a Dutch founder mutation. Functional analysis of this alteration revealed that transfected cells show altered subcellular localization, and significantly reduced binding affinity to CDK4 relative to wild type cells (McKenzie HA et al. Hum. Mutat. 2010 Jun;31:692-701). The relative risk for pancreatic cancer associated with this specific alteration ranges from 17% (95% CI 3&amp;ndash;30) to 47.8% (95% CI 28.4-74.7) (Vasen HF et al. Int. J. Cancer, 2000 Sep;87:809-11; de Snoo FA et al. Clin. Cancer Res. 2008 Nov;14:7151-7). Another study also found that smoking significantly increases risks of various cancers in carriers of this mutation (Potjer TP et al. Eur. J. Hum. Genet. 2015 May;23:711-4). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000077.4:c.225_243del19</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5042006" TraitType="Disease" MappingType="XRef" MappingValue="606719" MappingRef="OMIM">
        <MedGen CUI="C1838547" Name="Melanoma-pancreatic cancer syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7865318" TraitType="Disease" MappingType="XRef" MappingValue="155755" MappingRef="OMIM">
        <MedGen CUI="C1835042" Name="Melanoma and neural system tumor syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8791923" TraitType="Disease" MappingType="Name" MappingValue="CDKN2A-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="CDKN2A-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="376628" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1346889" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="381834" TraitType="Disease" MappingType="XRef" MappingValue="C1512419" MappingRef="MedGen">
        <MedGen CUI="C1512419" Name="Familial melanoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1133263" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

